Mentorship Program Alumni
Dr. Mohamed Bouattour & Dr. Erman Akkus
Dr. Mohamed Bouattour is a Medical Doctor specializing in Gastroenterology, Hepatology, and Digestive Oncology, currently leading the Liver Cancer and Innovation Therapy Unit at Beaujon University Hospital, France. With over a decade of experience, he is a recognized expert in the management of primary liver tumors and has led numerous innovative clinical trials in this field.
Dr. Erman Akkus is a medical oncology fellow and internal medicine consultant at the Department of Medical Oncology, Ankara University Faculty of Medicine in Ankara, Türkiye. He has been practicing as a physician for nine years, with a primary focus on gastrointestinal cancers, particularly hepatopancreaticobiliary malignancies.
Over the course of the program, Dr. Akkus and Dr. Bouattour designed a systematic review and meta-analysis focused on early-onset biliary tract cancers. This project enabled them to collaborate with leading experts involved in the COST Action network, representing four different countries. The manuscript is now in its final stages and will soon be submitted to a reputable, indexed journal.
|
Dr. James Cleary & Dr. Ana Landa Magdalena
Dr. James Cleary is a medical oncologist at the Dana-Farber Cancer Institute who specializes in treating gastrointestinal cancers. He is an Associate Professor of Medicine at Harvard Medical School and his research focuses on pancreas and biliary tract malignancies.
Dr. Ana Landa Magdalena completed her training as Medical Oncologist at San Sebastian University in 2020 and later completed her PhD on chemoresistance of CCA at BioGipuzcoa Health Research Institute, under the direction of Dr. Jesus Bañales and Dr. Pedro Rodrigues, in February of 2023. She is currently working on pancreatobiliary malignancies and early phase clinical trials at the Medical Oncology Department of the Cancer Center Clinical Universidad de Navarra, Spain, under the mentorship of Dr. Mariano Ponz.
Over the course of this program, Dr. Landa & Dr. Cleary had monthly meetings where Dr. Landa shared her ongoing projects, including the writing of the Ampullary Cancer Consensus Statement that she is developing on behalf of Precision-BTC Net WG3. Dr. Cleary’s opinions and advice have been invaluable for this work, as well as for other projects that Dr. Landa plans to undertake in the future.
|
Dr. Jill Koshiol & Dr. Yuewan Luo
Dr. Jill Koshiol is a Senior Investigator from NIH, focusing on Epidemiological studies of biliary tract cancer etiology and inflammation/immune response in the development of hepatocellular carcinoma.
Dr. Yuewan Luo is a postdoc from University of Copenhagen, Denmark, focusing on CCA therapeutic target and potential drug exploration via multi-omics and cell biology approaches.
Through this project, Dr. Yuewan enhanced her understanding in the CCA field, in scientific collaboration and her research questions and direction. Inspired by her mentor, she adopted a more consistent reading habit to support scientific growth and stay updated. The two also talked about potential cooperation in the future.
|
